| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.949 | 0.002 | 0.954 | Psychostimulant | 0.954 0.002 CID_457967 | CID_457967 | |
| 0.756 | 0.005 | 0.773 | 5 Hydroxytryptamine release stimulant | 0.773 0.004 CID_457967 | CID_457967 | |
| 0.697 | 0.014 | 0.742 | Analgesic | 0.742 0.009 CID_457967 | CID_457967 | |
| 0.618 | 0.003 | 0.618 | Acetylcholine nicotinic antagonist | 0.597 0.003 CID_457967 | ||
| 0.614 | 0.003 | 0.614 | Neuronal nicotinic receptor antagonist | 0.587 0.003 CID_457967 | ||
| 0.511 | 0.071 | 0.529 | Apoptosis agonist | 0.529 0.066 CID_457967 | CID_457967 | |
| 0.432 | 0.008 | 0.432 | Cholinergic | 0.393 0.01 CID_457967 | ||
| 0.387 | 0.008 | 0.454 | Acetylcholine antagonist | 0.454 0.005 CID_457967 | CID_457967 | |
| 0.382 | 0.004 | 0.466 | TRPA1 agonist | 0.466 0.003 CID_457967 | CID_457967 | |
| 0.384 | 0.009 | 0.452 | Cholinergic antagonist | 0.452 0.005 CID_457967 | CID_457967 | |
| 0.34 | 0.013 | 0.34 | Alpha adrenoreceptor antagonist | 0.211 0.026 CID_457967 | ||
| 0.304 | 0.002 | 0.304 | Nicotinic alpha3beta2 receptor antagonist | 0.294 0.002 CID_457967 | ||
| 0.302 | 0.006 | 0.302 | Alpha 2c adrenoreceptor antagonist | 0.236 0.012 CID_457967 | ||
| 0.297 | 0.008 | 0.297 | Alpha 2 adrenoreceptor antagonist | 0.224 0.014 CID_457967 | ||
| 0.258 | 0.005 | 0.258 | Acetylcholine M4 receptor antagonist | 0.172 0.008 CID_457967 | ||
| 0.265 | 0.013 | 0.265 | Alpha 2b adrenoreceptor antagonist | 0.207 0.022 CID_457967 | ||
| 0.26 | 0.01 | 0.279 | Neurotrophic factor | 0.279 0.009 CID_457967 | CID_457967 | |
| 0.254 | 0.009 | 0.254 | Alpha 2a adrenoreceptor antagonist | 0.213 0.012 CID_457967 | ||
| 0.249 | 0.005 | 0.256 | Antineoplastic alkaloid | 0.256 0.004 CID_457967 | CID_457967 | |
| 0.249 | 0.006 | 0.577 | NMDA 2 receptor antagonist | 0.577 0.003 CID_457967 | CID_457967 | |
| 0.249 | 0.008 | 0.356 | Dopamine D1 antagonist | 0.356 0.005 CID_457967 | CID_457967 | |
| 0.277 | 0.047 | 0.277 | 5 Hydroxytryptamine 1E antagonist | 0.263 0.061 CID_457967 | ||
| 0.251 | 0.025 | 0.303 | Acetylcholine M1 receptor antagonist | 0.303 0.014 CID_457967 | CID_457967 | |
| 0.274 | 0.048 | 0.387 | Tyrosine 3 hydroxylase inhibitor | 0.387 0.01 CID_457967 | CID_457967 | |
| 0.23 | 0.008 | 0.314 | Opioid kappa receptor antagonist | 0.314 0.005 CID_457967 | CID_457967 | |
| 0.324 | 0.118 | 0.438 | Antibacterial | 0.438 0.061 CID_457967 | CID_457967 | |
| 0.211 | 0.006 | 0.211 | Dopamine uptake inhibitor | 0.192 0.007 CID_457967 | ||
| 0.209 | 0.004 | 0.495 | NMDA receptor subunit 3B antagonist | 0.495 0.002 CID_457967 | CID_457967 | |
| 0.292 | 0.101 | 0.292 | Vasodilator, peripheral | 0.281 0.107 CID_457967 | ||
| 0.291 | 0.101 | 0.291 | Calcium channel activator | 0.232 0.169 CID_457967 | ||
| 0.203 | 0.014 | 0.203 | 5 Hydroxytryptamine agonist | 0.153 0.021 CID_457967 | ||
| 0.194 | 0.015 | 0.511 | NMDA receptor antagonist | 0.511 0.004 CID_457967 | CID_457967 | |
| 0.241 | 0.063 | 0.241 | Antimitotic | 0.169 0.105 CID_457967 | ||
| 0.192 | 0.015 | 0.192 | Acetylcholine agonist | 0.153 0.025 CID_457967 | ||
| 0.196 | 0.027 | 0.196 | 5 Hydroxytryptamine 2B antagonist | 0.128 0.053 CID_457967 | ||
| 0.173 | 0.005 | 0.173 | Nicotinic alpha4beta2 receptor antagonist | 0.161 0.006 CID_457967 | ||
| 0.186 | 0.022 | 0.189 | MAP3K9 inhibitor | 0.189 0.021 CID_457967 | CID_457967 | |
| 0.195 | 0.035 | 0.195 | 5 Hydroxytryptamine antagonist | 0.098 0.08 CID_457967 | ||
| 0.17 | 0.022 | 0.17 | Dopamine antagonist | 0.136 0.028 CID_457967 | ||
| 0.164 | 0.022 | 0.229 | Opioid antagonist | 0.229 0.01 CID_457967 | CID_457967 | |
| 0.154 | 0.017 | 0.154 | Acetylcholine M3 receptor agonist | 0.144 0.022 CID_457967 | ||
| 0.211 | 0.075 | 0.211 | Anticonvulsant | 0.208 0.077 CID_457967 | ||
| 0.141 | 0.006 | 0.141 | 5 Hydroxytryptamine 2A agonist | 0.117 0.01 CID_457967 | ||
| 0.147 | 0.016 | 0.147 | 5 Hydroxytryptamine uptake inhibitor | 0.12 0.02 CID_457967 | ||
| 0.163 | 0.04 | 0.163 | 5 Hydroxytryptamine 2 antagonist | 0.092 0.078 CID_457967 | ||
| 0.15 | 0.027 | 0.15 | 5 Hydroxytryptamine 2C antagonist | 0.082 0.059 CID_457967 | ||
| 0.128 | 0.006 | 0.404 | NMDA receptor subunit 3A antagonist | 0.404 0.003 CID_457967 | CID_457967 | |
| 0.126 | 0.008 | 0.131 | Nicotinic receptor alpha3 subunit antagonist | 0.131 0.007 CID_457967 | CID_457967 | |
| 0.131 | 0.013 | 0.158 | Glycine receptor antagonist | 0.158 0.006 CID_457967 | CID_457967 | |
| 0.159 | 0.05 | 0.159 | Acetylcholinesterase inhibitor | 0.13 0.069 CID_457967 | ||
| 0.279 | 0.175 | 0.37 | Calcium channel L-type activator | 0.37 0.103 CID_457967 | CID_457967 | |
| 0.127 | 0.024 | 0.127 | Acetylcholine nicotinic agonist | 0.121 0.026 CID_457967 | ||
| 0.126 | 0.023 | 0.189 | Opioid mu receptor antagonist | 0.189 0.01 CID_457967 | CID_457967 | |
| 0.228 | 0.127 | 0.235 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.235 0.121 CID_457967 | CID_457967 | |
| 0.11 | 0.01 | 0.11 | Nicotinic receptor alpha7 subunit antagonist | 0.095 0.013 CID_457967 | ||
| 0.105 | 0.007 | 0.106 | Nicotinic receptor alpha4 subunit antagonist | 0.106 0.007 CID_457967 | CID_457967 | |
| 0.119 | 0.026 | 0.12 | MAP-kinase-activated kinase inhibitor | 0.12 0.026 CID_457967 | CID_457967 | |
| 0.114 | 0.022 | 0.114 | MAP-kinase-activated kinase 2 inhibitor | 0.114 0.022 CID_457967 | ||
| 0.127 | 0.035 | 0.127 | Alpha 1 adrenoreceptor antagonist | |||
| 0.103 | 0.012 | 0.3 | NMDA 2A receptor antagonist | 0.3 0.004 CID_457967 | CID_457967 | |
| 0.119 | 0.03 | 0.119 | Alpha 1a adrenoreceptor antagonist | |||
| 0.139 | 0.051 | 0.176 | Acetylcholine muscarinic antagonist | 0.176 0.032 CID_457967 | CID_457967 | |
| 0.125 | 0.036 | 0.125 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.133 | 0.048 | 0.133 | Microtubule formation inhibitor | 0.127 0.053 CID_457967 | ||
| 0.162 | 0.078 | 0.162 | Sigma receptor agonist | 0.145 0.088 CID_457967 | ||
| 0.107 | 0.027 | 0.107 | Phosphodiesterase 11A inhibitor | 0.081 0.057 CID_457967 | ||
| 0.107 | 0.027 | 0.107 | Phosphodiesterase XI inhibitor | 0.081 0.057 CID_457967 | ||
| 0.091 | 0.01 | 0.127 | Opioid kappa receptor agonist | 0.127 0.007 CID_457967 | CID_457967 | |
| 0.124 | 0.044 | 0.124 | Antiadrenergic | 0.108 0.051 CID_457967 | ||
| 0.109 | 0.03 | 0.109 | Dopamine D2 antagonist | 0.082 0.039 CID_457967 | ||
| 0.168 | 0.092 | 0.168 | P-glycoprotein inhibitor | 0.147 0.122 CID_457967 | ||
| 0.113 | 0.043 | 0.184 | Prolactin inhibitor | 0.184 0.012 CID_457967 | CID_457967 | |
| 0.115 | 0.046 | 0.115 | Adrenaline antagonist | 0.1 0.054 CID_457967 | ||
| 0.134 | 0.067 | 0.134 | Tubulin antagonist | |||
| 0.091 | 0.025 | 0.091 | Acetylcholine M5 receptor agonist | |||
| 0.28 | 0.217 | 0.28 | Caspase 9 stimulant | 0.254 0.249 CID_457967 | ||
| 0.091 | 0.028 | 0.091 | Toll-Like receptor 7 antagonist | 0.066 0.05 CID_457967 | ||
| 0.128 | 0.069 | 0.13 | Vanilloid 1 agonist | 0.13 0.066 CID_457967 | CID_457967 | |
| 0.075 | 0.017 | 0.075 | 5 Hydroxytryptamine 2 agonist | 0.051 0.037 CID_457967 | ||
| 0.071 | 0.014 | 0.071 | 5 Hydroxytryptamine 2C agonist | 0.066 0.017 CID_457967 | ||
| 0.102 | 0.046 | 0.102 | Alpha 2d adrenoreceptor antagonist | 0.099 0.051 CID_457967 | ||
| 0.082 | 0.028 | 0.093 | Acetylcholine M2 receptor antagonist | 0.093 0.023 CID_457967 | CID_457967 | |
| 0.078 | 0.025 | 0.087 | Acetylcholine M5 receptor antagonist | 0.087 0.021 CID_457967 | CID_457967 | |
| 0.07 | 0.019 | 0.07 | Acetylcholine M2 receptor agonist | 0.066 0.022 CID_457967 | ||
| 0.204 | 0.155 | 0.208 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.208 0.144 CID_457967 | CID_457967 | |
| 0.071 | 0.026 | 0.071 | Acetylcholine muscarinic agonist | |||
| 0.052 | 0.012 | 0.052 | 5 Hydroxytryptamine 2B agonist | 0.038 0.029 CID_457967 | ||
| 0.166 | 0.127 | 0.166 | Cyclic AMP phosphodiesterase inhibitor | 0.166 0.127 CID_457967 | ||
| 0.059 | 0.02 | 0.059 | Mineralocorticoid receptor antagonist | 0.058 0.021 CID_457967 | ||
| 0.066 | 0.031 | 0.072 | Prolactin release inhibitor | 0.072 0.02 CID_457967 | CID_457967 | |
| 0.041 | 0.007 | 0.041 | Nicotinic alpha4beta2 receptor agonist | 0.037 0.01 CID_457967 | ||
| 0.077 | 0.045 | 0.077 | 5 Hydroxytryptamine 1F antagonist | 0.065 0.054 CID_457967 | ||
| 0.057 | 0.026 | 0.057 | Dopamine transporter inhibitor | 0.054 0.029 CID_457967 | ||
| 0.038 | 0.012 | 0.038 | Nicotinic alpha3beta4 receptor agonist | 0.038 0.011 CID_457967 | ||
| 0.065 | 0.041 | 0.065 | Dopamine D3 antagonist | |||
| 0.062 | 0.039 | 0.102 | Androgen agonist | 0.102 0.014 CID_457967 | CID_457967 | |
| 0.035 | 0.013 | 0.035 | Melatonin antagonist | |||
| 0.064 | 0.044 | 0.134 | Opioid delta receptor antagonist | 0.134 0.023 CID_457967 | CID_457967 | |
| 0.055 | 0.035 | 0.086 | Opioid agonist | 0.086 0.017 CID_457967 | CID_457967 | |
| 0.082 | 0.063 | 0.136 | Androgen antagonist | 0.136 0.027 CID_457967 | CID_457967 | |
| 0.061 | 0.042 | 0.075 | Alpha 2 adrenoreceptor agonist | 0.075 0.028 CID_457967 | CID_457967 | |
| 0.071 | 0.052 | 0.071 | Alpha 1b adrenoreceptor antagonist | |||
| 0.04 | 0.021 | 0.047 | Nociceptin (N/OFQ) receptor antagonist | 0.047 0.016 CID_457967 | CID_457967 | |
| 0.046 | 0.028 | 0.057 | Dopamine D5 antagonist | 0.057 0.021 CID_457967 | CID_457967 | |
| 0.023 | 0.005 | 0.023 | Nicotinic alpha4 receptor agonist | 0.018 0.009 CID_457967 | ||
| 0.038 | 0.022 | 0.038 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.139 | 0.123 | 0.153 | Lipocortins synthesis antagonist | 0.153 0.1 CID_457967 | CID_457967 | |
| 0.029 | 0.014 | 0.03 | 5 Hydroxytryptamine 1F agonist | 0.03 0.013 CID_457967 | CID_457967 | |
| 0.049 | 0.035 | 0.051 | Sigma receptor antagonist | 0.051 0.034 CID_457967 | CID_457967 | |
| 0.022 | 0.01 | 0.022 | Melatonin 1 antagonist | |||
| 0.057 | 0.045 | 0.057 | Bombesin 1 receptor agonist | 0.054 0.049 CID_457967 | ||
| 0.14 | 0.129 | 0.2 | Angiogenesis stimulant | 0.2 0.095 CID_457967 | CID_457967 | |
| 0.053 | 0.042 | 0.053 | Nicotinic neuronal receptor agonist | |||
| 0.031 | 0.021 | 0.031 | Acetylcholine M4 receptor agonist | |||
| 0.014 | 0.005 | 0.014 | Melatonin 2 antagonist | |||
| 0.056 | 0.049 | 0.056 | Potassium channel (Ca-activated) blocker | |||
| 0.046 | 0.04 | 0.046 | 5 Hydroxytryptamine 1 agonist | |||
| 0.05 | 0.044 | 0.05 | Alpha 1L adrenoreceptor antagonist | |||
| 0.034 | 0.03 | 0.057 | Kinesin-like protein 1 inhibitor | 0.057 0.014 CID_457967 | CID_457967 | |
| 0.034 | 0.03 | 0.057 | Kinesin antagonist | 0.057 0.014 CID_457967 | CID_457967 | |
| 0.029 | 0.028 | 0.029 | Melatonin agonist | |||
| 0.058 | 0.058 | 0.062 | Alpha adrenoreceptor agonist | 0.062 0.053 CID_457967 | CID_457967 | |
| 0.057 | 0.06 | 0.076 | Cyclin B3 inhibitor | 0.076 0.04 CID_457967 | CID_457967 | |
| 0.12 | 0.126 | 0.135 | GABA C receptor rho-2 antagonist | 0.135 0.097 CID_457967 | CID_457967 | |
| 0.047 | 0.059 | 0.075 | Acetylcholine M3 receptor antagonist | 0.075 0.028 CID_457967 | CID_457967 | |
| 0.051 | 0.065 | 0.055 | Lipocortins synthesis agonist | 0.055 0.048 CID_457967 | CID_457967 | |
| 0.035 | 0.05 | 0.056 | Opioid mu receptor agonist | 0.056 0.025 CID_457967 | CID_457967 | |
| 0.069 | 0.085 | 0.102 | MAP kinase kinase 7 inhibitor | 0.102 0.011 CID_457967 | CID_457967 | |
| 0.054 | 0.076 | 0.065 | Beta 3 adrenoreceptor antagonist | 0.065 0.043 CID_457967 | CID_457967 | |
| 0.131 | 0.157 | 0.155 | Death-associated protein kinase 2 inhibitor | 0.155 0.094 CID_457967 | CID_457967 | |
| 0.086 | 0.117 | 0.135 | Glutamate receptor antagonist | 0.135 0.061 CID_457967 | CID_457967 | |
| 0.065 | 0.109 | 0.095 | Topoisomerase I inhibitor | 0.095 0.074 CID_457967 | CID_457967 | |
| 0.181 | 0.225 | 0.256 | Interleukin 2 agonist | 0.256 0.113 CID_457967 | CID_457967 | |
| 0.128 | 0.174 | 0.205 | Neurotrophic factor enhancer | 0.205 0.072 CID_457967 | CID_457967 | |
| 0.11 | 0.165 | 0.14 | Anesthetic general | 0.14 0.125 CID_457967 | CID_457967 | |
| 0.084 | 0.14 | 0.133 | Estrogen antagonist | 0.133 0.035 CID_457967 | CID_457967 | |
| 0.048 | 0.105 | 0.078 | Analgesic, opioid | 0.078 0.05 CID_457967 | CID_457967 | |
| 0.146 | 0.212 | 0.21 | DNA synthesis inhibitor | 0.21 0.108 CID_457967 | CID_457967 | |
| 0.113 | 0.182 | 0.138 | MAP kinase kinase 4 inhibitor | 0.138 0.088 CID_457967 | CID_457967 | |
| 0.067 | 0.137 | 0.093 | CC chemokine 5 receptor agonist | 0.093 0.031 CID_457967 | CID_457967 | |
| 0.056 | 0.13 | 0.085 | Estrogen receptor alpha antagonist | 0.085 0.042 CID_457967 | CID_457967 | |
| 0.029 | 0.127 | 0.048 | NMDA 2B receptor antagonist | 0.048 0.047 CID_457967 | CID_457967 | |
| 0.017 | 0.116 | 0.051 | Dopamine D5 agonist | 0.051 0.017 CID_457967 | CID_457967 | |
| 0.058 | 0.166 | 0.115 | Estrogen receptor beta antagonist | 0.115 0.038 CID_457967 | CID_457967 | |
| 0.061 | 0.17 | 0.113 | GABA C receptor antagonist | 0.113 0.061 CID_457967 | CID_457967 | |
| 0.018 | 0.143 | 0.058 | NMDA 2C receptor antagonist | 0.058 0.048 CID_457967 | CID_457967 | |
| 0.018 | 0.158 | 0.041 | AMPA 4 receptor antagonist | 0.041 0.025 CID_457967 | CID_457967 | |
| 0.134 | 0.3 | 0.206 | Sodium/bile acid cotransporter inhibitor | 0.206 0.18 CID_457967 | CID_457967 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |